Abingdon Health Plc (ABDXF)
| Market Cap | 51.07M +23.4% |
| Revenue (ttm) | 14.59M +30.4% |
| Net Income | -2.82M |
| EPS | -0.01 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,000 |
| Open | 0.1281 |
| Previous Close | 0.1425 |
| Day's Range | 0.1281 - 0.1281 |
| 52-Week Range | 0.1214 - 0.2090 |
| Beta | 0.05 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 13, 2026 |
About Abingdon Health
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company also engages in manufacturing of lateral flow devices; and provision of support in meeting compliance requirements in international IVD and medical device markets. Its diagnostic products include PCRD: Nucleic acid lateral flow, a rapid, portable nucleic acid detection; Abi... [Read more]
Financial Performance
In fiscal year 2026, Abingdon Health's revenue was 10.99 million, an increase of 30.42% compared to the previous year's 8.43 million. Losses were -2.13 million, -37.69% less than in 2025.
Financial numbers in GBP Financial StatementsNews
Abingdon Health plc to Present at the Life Sciences Investor Forum on June 25th
The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at VirtualInvestorC...
Abingdon Health plc to Present at the Small Cap Growth Virtual Investor Conference June 4th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as ...